Wolters Kluwer Names Chris Sullivan Vice President Commercial Segment for Clinical Effectiveness

Rhea-AI Summary

Wolters Kluwer, Health has appointed Christopher Sullivan as the new Vice President and General Manager of the Commercial Segment for Clinical Effectiveness. With over 11 years at the company and previous leadership roles in product management and strategic partnerships, Sullivan will focus on enhancing the growth of clinical decision support (CDS) solutions like Medi-Span, Lexicomp, and UpToDate. His leadership is pivotal in expanding the company's footprint in the commercial market.

Positive

• Christopher Sullivan appointed as Vice President and General Manager, indicating a strategic leadership move.
• Sullivan has over 11 years of relevant experience at Wolters Kluwer, likely enhancing operational effectiveness.
• Focus on growth in clinical decision support (CDS) solutions aligns with market demand.

Negative

• None.

WALTHAM, Mass.--(BUSINESS WIRE)-- Wolters Kluwer, Health today announced that Christopher Sullivan has been appointed as Vice President and General Manager of the Commercial Segment for Clinical Effectiveness.

In his 11 years at Wolters Kluwer, Sullivan has held a range of leadership positions in strategy, product management, pricing, and strategic partnerships. Most recently he served as Vice President and General Manager of the Transactional & Retirement Portfolio in Wolters Kluwer’s Legal & Regulatory division, where he oversaw a portfolio of SaaS solutions and expert content serving legal and compliance professionals.

In his new role, Sullivan will lead the Commercial Segment with responsibility for setting strategy and driving growth of its clinical decision support (CDS) solutions including Medi-Span^®, Lexicomp^®, UpToDate^® and Emmi^®. The segment provides expert content and workflow tools to professionals in the pharmacy, digital health technology, and commercial payer markets. Sullivan reports to Greg Samios, President and CEO of Clinical Effectiveness, Wolters Kluwer, Health.

“Expanding our footprint in the commercial market is a critical part of our overall strategy,” said Samios. “With his strong background and proven results at Wolters Kluwer, I am confident that Chris will scale our commercial footprint as we accelerate development of impactful solutions for our customers.”

“I’m honored to lead the Commercial Segment as we ramp up investment in the business,” said Sullivan. “These are pivotal times in healthcare—our portfolio is the lifeblood of clinicians worldwide, and we are committed to helping our clients achieve better outcomes at greater speed.”

Prior to joining Wolters Kluwer, Sullivan held a variety of operations management roles at DHL. He earned an MBA from Fordham University and a BS from the United States Military Academy at West Point.

About Wolters Kluwer
Wolters Kluwer (WKL) is a global leader in professional information, software solutions, and services for the clinicians, nurses, accountants, lawyers, and tax, finance, audit, risk, compliance, and regulatory sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with advanced technology and services.

Wolters Kluwer reported 2020 annual revenues of €4.6 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 19,200 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.

Wolters Kluwer provides trusted clinical technology and evidence-based solutions that engage clinicians, patients, researchers and students in effective decision-making and outcomes across healthcare. We support clinical effectiveness, learning and research, clinical surveillance and compliance, as well as data solutions. For more information about our solutions, visit https://www.wolterskluwer.com/en/health and follow us on LinkedIn and Twitter @WKHealth.

For more information, visit www.wolterskluwer.com, follow us on Twitter, Facebook, LinkedIn, and YouTube.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220921005261/en/

Media:

André Rebelo

Sr. Global Public Relations Manager

Wolters Kluwer Health

+1 (781) 392-2411

andre.rebelo@wolterskluwer.com

Source: Wolters Kluwer Health

FAQ

What is Christopher Sullivan's role at WTKWY?

Christopher Sullivan has been appointed as the Vice President and General Manager of the Commercial Segment for Clinical Effectiveness at Wolters Kluwer, Health.

What experience does Christopher Sullivan bring to WTKWY?

Christopher Sullivan has over 11 years of experience at Wolters Kluwer, holding various leadership roles in strategy, product management, and pricing.

What are the key products under Sullivan's leadership at WTKWY?

Under Christopher Sullivan's leadership, key products include Medi-Span, Lexicomp, UpToDate, and Emmi.

Why is Sullivan's appointment important for WTKWY?

Sullivan's appointment is crucial as it aims to expand Wolters Kluwer's footprint in the commercial market, enhancing growth strategies.

What is the strategic focus for WTKWY under Sullivan's management?

The strategic focus under Sullivan's management will be on driving growth in clinical decision support solutions.